The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
Onconick sp. z o. o.
+ business areaBioPharma R&D+Services
+ annual revenue
2021 - 0 PLN
2022 - 0 PLN
2023 - 92,1 PLN
+ workforce (estimated if not reported)
2019 -
2020 -
2021 -
2022 -
2023 -
2024 -
+ depreciation & amortization
2019 -
2020 -
2021 -
2022 -
2023 -
2024 -
Onconick is a Polish biotechnology company specializing in precision oncology, developing next-generation antibody-drug conjugates (ADCs) for lung and breast cancer. Founded by scientists from the University of Wrocław, the company combines world-class expertise in recombinant protein engineering with a proprietary platform for molecular target selection, antibody characterization, and ADC development. Its technology is designed to deliver cytotoxic agents exclusively to cancer cells, increasing treatment efficacy while minimizing side effects.